Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_086c777a88d48fb03acd8e61ed72611c http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_db3be89de48adb30132f44f1e098c7cc http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bf13596c2f45c98d02044fcb0e0e5517 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_96472ed51f7a84ad5d65a0b10a69f68c http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1c8cbbf2290b3f3a9988da29598baa2c |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-554 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J43-003 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J41-0061 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J9-005 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-165 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K- http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-575 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-522 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J41-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J9-00 |
filingDate |
2001-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9dd23fd7172b60102908a7bc9ebba78a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_11b37a52ed5773cd2c868fccaa337da5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b2c2830d77d6f708c713618519f4fe35 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b1b9e1099320bae7e8dc3b6869396f41 |
publicationDate |
2001-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-0176531-A2 |
titleOfInvention |
Bile acid containing prodrugs with enhanced bioavailability |
abstract |
Many compounds have poor bioavailability or variable bioavailability because of poor absorption of the compound in the small intestine. Conjugation of the compound with bile acid to form a prodrug will increase the bioavailibility of the compound and/or reduce the bioavailability variability of the compound because of the active transport of the prodrug by the intestinal bile acid transporter and because of increased lipophilic nature of the prodrug. A linker group can be used between the bile acid and the compound. One example of a bile acid containing prodrug is acyclovir valylchenodeoxycholate, where valine is the linker group. Another example of this prodrug is atenolol cholic acid amide. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1343805-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10350169-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7989417-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1343805-A4 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1358200-A4 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7678782-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7598235-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7144877-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6984634-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009530399-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1358200-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2006513247-A |
priorityDate |
2000-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |